Corinth, TX, United States of America

Cameron Currington

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Uniwell Laboratories, LLC. Active years: 2021.


% Patents Active = 100.0


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cameron Currington: Innovator in Pharmaceutical Compositions

Introduction

Cameron Currington is a notable inventor based in Corinth, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of dosage accuracy. His innovative approach has the potential to enhance the effectiveness of pharmaceutical products.

Latest Patents

Cameron Currington holds 1 patent for his invention related to pharmaceutical compositions. His patent focuses on a method for dosing a pharmaceutical product in a sealed container, such as a packet, sachet, or blister pack. This method ensures high accuracy in measuring specific volumes and weights of each component in a dosage. The invention includes a thickening agent that serves as a carrier for the active ingredient, allowing it to dissolve in the mouth without the need for water.

Career Highlights

Cameron is currently associated with Uniwell Laboratories, LLC, where he applies his expertise in pharmaceutical innovations. His work is pivotal in developing products that require precise dosing, which is crucial for patient safety and efficacy.

Collaborations

Cameron collaborates with talented individuals such as Alan Jones and Cesar Rodriguez. Their combined efforts contribute to the advancement of pharmaceutical technologies and innovations.

Conclusion

Cameron Currington's work in pharmaceutical compositions exemplifies the importance of innovation in healthcare. His dedication to improving dosage accuracy is a testament to his commitment to enhancing patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…